Nationwide Fund Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-26,650
Closed -$1.81M 210
2017
Q3
$1.81M Buy
26,650
+450
+2% +$28.4K 0.01% 1489
2017
Q2
$1.79M Buy
26,200
+450
+2% +$29.4K 0.01% 1480
2017
Q1
$1.6M Buy
25,750
+950
+4% +$55.3K 0.01% 1508
2016
Q4
$1.35M Sell
24,800
-1,200
-5% -$68.1K 0.01% 1612
2016
Q3
$1.71M Sell
26,000
-800
-3% -$52.3K 0.01% 1476
2016
Q2
$1.62M Sell
26,800
-2,000
-7% -$116K 0.01% 1468
2016
Q1
$1.62M Sell
28,800
-146,035
-84% -$8.77M 0.01% 1453
2015
Q4
$11.9M Buy
174,835
+1,300
+0.7% +$85.2K 0.05% 494
2015
Q3
$11M Sell
173,535
-30,850
-15% -$2.03M 0.05% 485
2015
Q2
$13M Buy
204,385
+5,280
+3% +$362K 0.05% 450
2015
Q1
$13.6M Buy
199,105
+13,200
+7% +$917K 0.05% 449
2014
Q4
$13.1M Buy
185,905
+85,300
+85% +$6.11M 0.06% 438
2014
Q3
$7.19M Sell
100,605
-300
-0.3% -$22K 0.03% 752
2014
Q2
$7.5M Buy
+100,905
New +$7.29M 0.03% 744
2014
Q1
Sell
-51,500
Closed -$3.06M 3135
2013
Q4
$3.06M Buy
51,500
+600
+1% +$32.6K 0.01% 1231
2013
Q3
$2.64M Buy
+50,900
New +$2.56M 0.01% 1265

Other funds holding AZN

Nationwide Fund Advisors's AZN Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of AstraZeneca (AZN) in Q4 2017, closing a stake of 26,650 shares — an estimated $1.81M sold.

Nationwide Fund Advisors first reported a position in AZN in Q3 2013 and held it in 16 quarters. The position peaked at $13.6M in Q1 2015. 503 funds tracked by Wall St. Rank hold AZN as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining AstraZeneca position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 26,650 AstraZeneca shares in Q4 2017, an estimated $1.81M.
  • Nationwide Fund Advisors first reported a position in AstraZeneca in Q3 2013 and held it in 16 quarters.
  • Nationwide Fund Advisors's AstraZeneca position peaked at $13.6M in Q1 2015.
  • 503 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.